Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Journal for ImmunoTherapy of Cancer | journal | 3.728 Q1 | 117 | 445 | 1590 | 19408 | 14743 | 1571 | 8.71 | 43.61 | 42.99 | |
2 | npj Vaccines | journal | 2.127 Q1 | 47 | 182 | 421 | 9795 | 2689 | 404 | 6.60 | 53.82 | 45.87 | |
3 | Asian Journal of Pharmaceutical Sciences | journal | 1.662 Q1 | 66 | 61 | 187 | 5119 | 2030 | 181 | 10.84 | 83.92 | 46.37 | |
4 | Interdisciplinary Toxicology | journal | 1.583 Q1 | 38 | 0 | 6 | 0 | 74 | 6 | 0.00 | 0.00 | 0.00 | |
5 | International Journal of Neuropsychopharmacology | journal | 1.525 Q1 | 125 | 79 | 261 | 4188 | 1265 | 254 | 4.59 | 53.01 | 45.25 | |
6 | PharmacoEconomics | journal | 1.517 Q1 | 118 | 106 | 332 | 5784 | 1361 | 286 | 3.88 | 54.57 | 46.30 | |
7 | Biomedicine and Pharmacotherapy | journal | 1.493 Q1 | 149 | 1846 | 4194 | 172678 | 31849 | 4177 | 7.20 | 93.54 | 46.23 | |
8 | CNS Neuroscience and Therapeutics | journal | 1.473 Q1 | 91 | 418 | 491 | 24328 | 2516 | 434 | 4.95 | 58.20 | 43.37 | |
9 | Therapeutic Advances in Neurological Disorders | journal | 1.436 Q1 | 68 | 91 | 251 | 4803 | 1134 | 239 | 4.44 | 52.78 | 37.62 | |
10 | Expert Review of Vaccines | journal | 1.412 Q1 | 105 | 110 | 409 | 7915 | 2013 | 364 | 5.10 | 71.95 | 43.87 | |
11 | Journal of Xenobiotics | journal | 1.246 Q1 | 11 | 48 | 41 | 3816 | 302 | 40 | 7.37 | 79.50 | 46.05 | |
12 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.220 Q1 | 47 | 43 | 142 | 2437 | 622 | 142 | 4.21 | 56.67 | 43.39 | |
13 | Vaccines | journal | 1.201 Q1 | 85 | 1854 | 4462 | 105389 | 22996 | 4375 | 5.37 | 56.84 | 46.93 | |
14 | Frontiers in Pharmacology | journal | 1.066 Q1 | 154 | 3463 | 11918 | 215854 | 56071 | 11495 | 4.32 | 62.33 | 45.82 | |
15 | Drug Design, Development and Therapy | journal | 0.999 Q1 | 94 | 271 | 1141 | 13688 | 5855 | 1136 | 4.89 | 50.51 | 45.28 | |
16 | Biomarker Insights | journal | 0.974 Q1 | 40 | 9 | 67 | 468 | 246 | 59 | 3.34 | 52.00 | 50.00 | |
17 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.949 Q1 | 92 | 212 | 573 | 12376 | 3394 | 573 | 5.93 | 58.38 | 43.02 | |
18 | Human Vaccines and Immunotherapeutics | journal | 0.927 Q2 | 93 | 516 | 1849 | 21250 | 7046 | 1639 | 3.81 | 41.18 | 49.06 | |
19 | Cancer Biology and Therapy | journal | 0.914 Q2 | 130 | 83 | 267 | 3691 | 956 | 263 | 4.32 | 44.47 | 45.15 | |
20 | Chinese Medicine | journal | 0.877 Q2 | 56 | 159 | 409 | 11306 | 2115 | 406 | 5.30 | 71.11 | 43.23 | |
21 | Journal of Pharmacological Sciences | journal | 0.876 Q2 | 101 | 80 | 324 | 3004 | 1106 | 324 | 3.23 | 37.55 | 31.80 | |
22 | Cancer Chemotherapy and Pharmacology | journal | 0.869 Q2 | 122 | 109 | 496 | 3935 | 1395 | 488 | 2.73 | 36.10 | 37.56 | |
23 | EJNMMI Radiopharmacy and Chemistry | journal | 0.869 Q2 | 28 | 42 | 99 | 1553 | 398 | 95 | 3.59 | 36.98 | 37.30 | |
24 | Pharmacological Reports | journal | 0.867 Q2 | 98 | 117 | 404 | 9099 | 1689 | 399 | 3.74 | 77.77 | 52.99 | |
25 | EXCLI Journal | journal | 0.853 Q2 | 55 | 94 | 353 | 5995 | 1144 | 256 | 3.13 | 63.78 | 41.51 | |
26 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.835 Q2 | 64 | 368 | 1259 | 16211 | 4174 | 1243 | 2.88 | 44.05 | 48.16 | |
27 | Medicine in Drug Discovery | journal | 0.815 Q2 | 16 | 20 | 68 | 1878 | 328 | 65 | 4.83 | 93.90 | 45.00 | |
28 | Drugs in Context | journal | 0.811 Q2 | 36 | 58 | 193 | 3370 | 574 | 193 | 2.46 | 58.10 | 41.20 | |
29 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 41 | 153 | 1868 | 578 | 152 | 3.76 | 45.56 | 30.72 | |
30 | Cardiovascular Therapeutics | journal | 0.769 Q2 | 54 | 34 | 165 | 1509 | 544 | 165 | 3.43 | 44.38 | 38.42 | |
31 | Pharmaceutical Biology | journal | 0.754 Q2 | 88 | 134 | 526 | 6483 | 2160 | 524 | 4.06 | 48.38 | 45.80 | |
32 | Altex | journal | 0.745 Q2 | 64 | 59 | 180 | 2494 | 580 | 166 | 2.96 | 42.27 | 48.62 | |
33 | Natural Products and Bioprospecting | journal | 0.745 Q2 | 36 | 53 | 134 | 3424 | 657 | 132 | 4.95 | 64.60 | 43.34 | |
34 | Infection and Drug Resistance | journal | 0.743 Q2 | 65 | 698 | 1733 | 27973 | 5784 | 1701 | 2.87 | 40.08 | 44.32 | |
35 | Medical Cannabis and Cannabinoids | journal | 0.731 Q2 | 13 | 19 | 41 | 621 | 168 | 34 | 3.65 | 32.68 | 39.53 | |
36 | BMC pharmacology & toxicology | journal | 0.710 Q2 | 43 | 77 | 253 | 2925 | 763 | 253 | 2.92 | 37.99 | 43.47 | |
37 | Drugs in R and D | journal | 0.708 Q2 | 54 | 40 | 111 | 1687 | 296 | 107 | 2.41 | 42.18 | 50.97 | |
38 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.696 Q2 | 57 | 27 | 169 | 1330 | 433 | 166 | 2.60 | 49.26 | 34.83 | |
39 | Journal of Cannabis Research | journal | 0.692 Q2 | 17 | 39 | 148 | 1666 | 627 | 144 | 4.35 | 42.72 | 47.62 | |
40 | Drug Metabolism and Pharmacokinetics | journal | 0.674 Q2 | 75 | 38 | 182 | 1462 | 454 | 179 | 2.94 | 38.47 | 27.18 | |
41 | Neuropsychopharmacology Reports | journal | 0.660 Q2 | 22 | 105 | 201 | 3867 | 480 | 199 | 2.40 | 36.83 | 28.02 | |
42 | PharmacoEconomics - Open | journal | 0.658 Q2 | 20 | 74 | 207 | 3193 | 381 | 197 | 1.94 | 43.15 | 43.63 | |
43 | Contemporary Clinical Trials Communications | journal | 0.636 Q2 | 26 | 176 | 511 | 7402 | 849 | 507 | 1.52 | 42.06 | 55.37 | |
44 | DARU, Journal of Pharmaceutical Sciences | journal | 0.625 Q2 | 58 | 43 | 149 | 2213 | 587 | 146 | 2.80 | 51.47 | 51.06 | |
45 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.619 Q2 | 88 | 22 | 121 | 0 | 378 | 121 | 2.95 | 0.00 | 44.76 | |
46 | International Journal of Immunopathology and Pharmacology | journal | 0.611 Q2 | 65 | 76 | 245 | 3167 | 723 | 219 | 2.88 | 41.67 | 48.65 | |
47 | Journal of Food and Drug Analysis | journal | 0.609 Q2 | 79 | 50 | 149 | 3032 | 569 | 147 | 2.60 | 60.64 | 39.13 | |
48 | Saudi Pharmaceutical Journal | journal | 0.598 Q2 | 76 | 306 | 570 | 15319 | 2216 | 566 | 3.26 | 50.06 | 39.89 | |
49 | Current Pharmaceutical Design | journal | 0.586 Q2 | 183 | 316 | 1278 | 27228 | 3460 | 1174 | 2.55 | 86.16 | 44.50 | |
50 | Drug, Healthcare and Patient Safety | journal | 0.571 Q3 | 30 | 16 | 76 | 757 | 205 | 76 | 2.52 | 47.31 | 38.71 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®